Financial Performance - Q3 2025 net revenue was $26.1 million, with MIPLYFFA® contributing $22.4 million, compared to $3.7 million in Q3 2024[7] - Zevra Therapeutics reported net revenue of $26,063,000 for the three months ended September 30, 2025, compared to $3,695,000 for the same period in 2024, representing a significant increase of 605%[31] - The company reported a net income of $71,064,000 for the nine months ended September 30, 2025, compared to a net loss of $69,772,000 for the same period in 2024[31] Operating Expenses - Operating expenses decreased to $20.4 million in Q3 2025 from $27.2 million in Q3 2024, with R&D expenses down to $3.4 million[7] - The company’s total operating expenses for the nine months ended September 30, 2025, were $67,385,000, a decrease of 7% from $72,486,000 in the same period of 2024[31] - Zevra's research and development expenses for the three months ended September 30, 2025, were $3,432,000, a decrease of 69.7% from $10,945,000 in the same period of 2024[31] - The company’s selling, general and administrative expenses for the nine months ended September 30, 2025, were $57,262,000, an increase of 47.5% from $38,743,000 in the same period of 2024[31] Loss and Cash Position - Net loss for Q3 2025 was $(0.5) million, or $(0.01) per share, significantly improved from a net loss of $(33.2) million, or $(0.69) per share, in Q3 2024[7] - Cash position stood at $230.4 million as of September 30, 2025, providing sufficient resources for strategic priorities[7] - Zevra's cash and cash equivalents increased to $54,439,000 as of September 30, 2025, up from $33,785,000 at the end of 2024, indicating improved liquidity[33] - The company’s accumulated deficit improved to $(434,225,000) as of September 30, 2025, compared to $(505,289,000) at the end of 2024[33] Market Access and Product Development - MIPLYFFA achieved market access for 66% of covered lives, while OLPRUVA reached 81%[5] - A Marketing Authorization Application for arimoclomol is under review by the European Medicines Agency[5] - MIPLYFFA has been designated as an Orphan Medicinal Product by the EMA, highlighting its significance in treating Niemann-Pick disease type C[12] - The company plans to scale back sales and marketing efforts for OLPRUVA while maintaining product availability[5] Clinical Trials - Five patients were enrolled in the Phase 3 DiSCOVER trial for Celiprolol, totaling 44 enrolled patients[5] - MIPLYFFA's clinical data showed a decline in annual disease progression for patients switching from placebo[7] Assets and Liabilities - The total assets of Zevra Therapeutics rose to $270,116,000 as of September 30, 2025, compared to $178,127,000 at the end of 2024, reflecting a growth of 51.7%[33] - Zevra's total liabilities decreased slightly to $136,951,000 as of September 30, 2025, from $138,461,000 at the end of 2024[33] Shareholder Information - The weighted-average shares of common stock outstanding increased to 55,951,572 for the three months ended September 30, 2025, compared to 47,808,817 for the same period in 2024[31]

Zevra Reports Third Quarter 2025 Financial Results and Corporate Update 2025 EPS of $(0.01) Q3 2025 net revenue of $26.1 million, driven by MIPLYFFA® net revenue of $22.4 million Company to host conference call and webcast TODAY, November 5, 2025, at 4:30 p.m. ET CELEBRATION, Fla., November 5, 2025 -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results for the th ...

Revenue Growth - Year-to-date revenue increased by 65% and volume by 74% compared to the previous year[1] - Third quarter revenue growth year-over-year was 70%, with volume growth of 56%[3] - Revenue for the third quarter was $393.5 million, with APA contributing $16.9 million[5] - Total revenue for the three months ended September 30, 2025, was $393,491 thousand, representing a 70.4% increase from $231,406 thousand in the same period of 2024[28] - Revenue for the three months ended September 30, 2025, was $393,491,000, a significant increase from $231,406,000 in the same period of 2024, representing a growth of 70%[32] - Full-year revenue guidance is projected to be between $1.25 billion and $1.28 billion, including approximately $50 million from APA[6] Profitability Metrics - Adjusted EBITDA for the full year is expected to range from $185 million to $195 million[6] - Adjusted EBITDA for the nine months ended September 30, 2025, was $176,336,000, up from $128,353,000 in 2024, indicating a growth of 37.4%[34] - Adjusted net income per share is projected to be between $0.64 and $0.70[6] - Adjusted net income for the nine months ended September 30, 2025, was $104,235,000, an increase from $66,080,000 in 2024, representing a growth of 57.8%[34] - Net income for the three months ended September 30, 2025, was $33,503 thousand, compared to a net loss of $141,354 thousand in the same period of 2024[28] - The company reported a basic income per common share of $0.12 for the three months ended September 30, 2025, recovering from a loss of $1.02 in the same quarter of 2024[34] Expenses and Cash Flow - The company incurred total operating expenses of $160,112 thousand for the nine months ended September 30, 2025, compared to $304,017 thousand in 2024, a decrease of 47.4%[28] - Operating cash flow for the nine months ended September 30, 2025, was $58,145 thousand, down from $96,394 thousand in the same period of 2024[30] - Free cash flow for the three months ended September 30, 2025, was $21,850,000, compared to $43,858,000 in the same period of 2024[36] - General and administrative expenses for the three months ended September 30, 2025, totaled $52,248,000, compared to $40,149,000 in 2024, reflecting an increase of 30.1%[36] Balance Sheet Highlights - Total assets increased to $1,611,161 thousand as of September 30, 2025, from $1,425,999 thousand as of December 31, 2024, reflecting a growth of 13.0%[26] - Total liabilities rose to $1,206,572 thousand as of September 30, 2025, compared to $1,137,164 thousand as of December 31, 2024, marking a 6.1% increase[26] - Cash and cash equivalents decreased to $221,516 thousand as of September 30, 2025, down from $362,992 thousand as of December 31, 2024[26] Strategic Initiatives - The acquisition of APA is expected to enhance top-line expansion and profitability[4] - The company anticipates continued growth in 2026 with the launch of new integrated tracker and software solutions[4] Other Notable Events - The company reported a significant goodwill impairment of $162,000 thousand in the three months ended September 30, 2024[28] - The company is awaiting a decision on an appeal related to legal costs associated with litigation dismissed in May 2023, which may impact future financials[35]

Financial Performance - Revenue for Q3 2025 was $1,405 million, a 68% increase from $835 million in Q3 2024[2] - Net income for Q3 2025 reached $836 million, up 92% from $434 million in Q3 2024[2] - Adjusted EBITDA for Q3 2025 was $1,158 million, reflecting a 79% increase compared to $647 million in Q3 2024[2] - Revenue for Q3 2025 reached $1,405,045, a 68% increase from $835,186 in Q3 2024[18] - Net income for the nine months ended September 30, 2025, was $2,231,495, compared to $980,572 for the same period in 2024, reflecting a 127% increase[19] - Adjusted EBITDA for Q3 2025 was $1,157,654, representing a 79% increase from $647,017 in Q3 2024[21] - Basic net income per share for Q3 2025 was $2.47, compared to $1.29 in Q3 2024, reflecting a 92% increase[18] Cash Flow and Operating Activities - Net cash from operating activities and Free Cash Flow for Q3 2025 were both $1.05 billion[5] - The net cash provided by operating activities for the nine months ended September 30, 2025, was $2,657,360, up from $1,398,008 in 2024[19] - Free Cash Flow for Q3 2025 was $1,048,999, compared to $545,095 in Q3 2024, indicating a 92% increase[20] - Cash and cash equivalents at the end of Q3 2025 were $1,666,899, significantly higher than $567,596 at the end of Q3 2024[19] Shareholder Actions - The company repurchased 1.3 million shares of Class A common stock for a total cost of $571 million during Q3 2025[5] - The board of directors increased the share repurchase authorization by $3.2 billion, bringing the total remaining authorization to $3.3 billion[5] Assets and Liabilities - Total assets as of September 30, 2025, were $6,343 million, compared to $5,869 million as of December 31, 2024[17] - Total liabilities as of September 30, 2025, were $4,869 million, an increase from $4,779 million as of December 31, 2024[17] - Retained earnings increased to $1,048 million as of September 30, 2025, up from $599 million as of December 31, 2024[17] Costs and Expenses - Total costs and expenses for Q3 2025 were $326,038, compared to $300,887 in Q3 2024, an 8% increase[18] Other Financial Metrics - The company reported a net margin of 59% for Q3 2025, up from 52% in Q3 2024[21] - The company incurred a goodwill impairment of $188,943 in the nine months ended September 30, 2025[19]

Financial Performance - Total revenue for Q3 2025 reached $8,981,459, a 23.3% increase from $7,287,941 in Q3 2024[19] - Net income for Q3 2025 was $1,072,295, compared to $366,021 in Q3 2024, representing a 194.5% increase[19] - Operating income for the nine months ended September 30, 2025, was $8,602,597, significantly higher than $2,813,088 for the same period in 2024[19] - Net income for the nine months ended September 30, 2025, was $6,639,790, compared to $2,688,577 for the same period in 2024, representing a significant increase[24] - Total operating revenue for the nine months ended September 30, 2025, was $36,769,332, a 62.7% increase compared to $22,582,502 for the same period in 2024[72] - The net income for the three months ended September 30, 2025, was $1,072,295, compared to $366,021 for the same period in 2024, indicating a significant increase of 194%[92] - For the nine months ended September 30, 2025, net income reached $6,639,790, up from $2,688,577 in 2024, reflecting a growth of 147%[92] Cash and Assets - Cash and cash equivalents increased to $12,766,167 as of September 30, 2025, up from $6,519,793 at December 31, 2024[17] - Total assets grew to $126,293,005 as of September 30, 2025, compared to $120,454,785 at December 31, 2024[17] - Total cash, cash equivalents, and restricted cash at the end of the period was $13,236,167, up from $8,774,971 at the end of the same period in 2024[24] - The company had a working capital surplus of $9.2 million as of September 30, 2025, up from $7.2 million at the end of 2024[171] Liabilities and Equity - Total current liabilities increased to $9,924,626 as of September 30, 2025, compared to $6,980,007 at December 31, 2024[17] - The accumulated deficit decreased to $(38,995,173) as of September 30, 2025, from $(41,505,076) at December 31, 2024[21] - Operating lease liabilities totaled $387,062 as of September 30, 2025, down from $476,911 at the end of 2024, a reduction of approximately 18.8%[88] - The company had commitments of $0.2 million for capital expenditures as of September 30, 2025[86] Revenue Breakdown - Gas, oil, NGL, and condensate revenue for Q3 2025 was $7,536,248, up from $6,203,953 in Q3 2024, marking a 21.5% increase[19] - Natural gas revenue for the three months ended September 30, 2025, was $4,758,578, up 150.5% from $1,903,946 in the same period of 2024[72] - Upstream natural gas revenue for the nine months ended September 30, 2025, increased by $15.5 million, or 226%, compared to the same period in 2024[148] - Upstream oil and condensate revenue for the nine months ended September 30, 2025, decreased by $1.7 million, or 17%, compared to the same period in 2024[150] Expenses and Impairments - Stock-based compensation expense for the nine months ended September 30, 2025, was $1,148,289, compared to $944,267 in 2024, reflecting increased compensation costs[24] - The company experienced an impairment expense of $2,676,669 in 2025, which was not present in 2024, indicating potential challenges in asset valuation[24] - The company recorded an impairment of $2.7 million for two wells in Alberta, Canada, due to lower than expected production and cost overruns[48] - General and administrative expenses for the three months ended September 30, 2025, increased by $1.1 million, or 62%, compared to the same period in 2024, primarily due to transaction expenses related to the pending Peak acquisition[162] Acquisitions and Investments - The company plans to acquire Peak Exploration and Production LLC and Peak BLM Lease LLC for a total consideration of 6 million common shares and the assumption of approximately $51.2 million in debt, expected to close in Q4 2025[28] - The acquisition will include 40,500 net acres producing 2.2 MBoepd in the Powder River Basin, enhancing the company's asset base[28] - Epsilon acquired a 25% interest in three producing wells and 3,620 gross undeveloped acres in Ector County, Texas, with total capital expenditures of $42 million through September 30, 2025[131] Derivative Contracts and Risk Management - The company engaged in price risk management activities to mitigate exposure to fluctuations in commodity prices for natural gas and oil through derivative contracts[102] - Epsilon Energy Ltd. recognized gains on commodity derivative contracts of $964,307 and $2,076,000 for the three and nine months ended September 30, 2025, respectively, compared to $440,712 and $245,095 for the same periods in 2024[106] - The net fair value of derivatives at September 30, 2025, was $889,187, an increase from a net liability of $487,548 at December 31, 2024[108] Tax and Compliance - The Company reported total current income tax expense of $473,344 for the three months ended September 30, 2025, compared to a tax benefit of $(270,426) in 2024[81] - The effective tax rate for the nine months ended September 30, 2025, was higher than the statutory federal rate due to state income taxes and valuation allowances against Canadian net operating losses[84] - Epsilon Energy Ltd. filed certifications under Sarbanes-Oxley Section 302 for both the Principal Executive Officer and Principal Financial Officer[204] Future Outlook - The company has focused recent investments in the Permian Basin in Texas and the Western Canadian Sedimentary Basin in Alberta, Canada[130] - Epsilon's business strategy includes disciplined capital allocation and maintaining a strong balance sheet to invest in existing and potential new projects[129]

Financial Performance - Q3'25 revenues increased by 6% year-over-year to $96.2 million, compared to $90.7 million in Q3'24[8] - Net income attributable to Safehold Inc. rose by 51% year-over-year to $29.3 million, up from $19.3 million in Q3'24[8] - Earnings per share (EPS) increased by 52% year-over-year to $0.41, compared to $0.27 in Q3'24[8] - Net income attributable to Safehold Inc. common shareholders for Q3 2025 was $29.282 million, an increase of 51.7% compared to $19.331 million in Q3 2024[30] - EPS excluding non-recurring gains/losses for Q3 2025 was $0.41, compared to $0.37 in Q3 2024, reflecting an increase of 10.8%[30] - The company reported a net income excluding non-recurring gains/losses of $88.538 million for the nine months ended September 30, 2025, compared to $86.528 million for the same period in 2024, an increase of 2.3%[30] Portfolio and Assets - The Core Ground Lease Portfolio gross book value reached $6.9 billion, with a weighted average lease term of 91 years[10][14] - Total portfolio square footage increased to 37.2 million square feet, with 155 total assets[7] - Total assets as of September 30, 2025, reached $7.148 billion, up from $6.899 billion as of December 31, 2024, reflecting a growth of 3.6%[27] - The company's net investment in sales-type leases increased to $3.527 billion as of September 30, 2025, compared to $3.454 billion at the end of 2024, marking a rise of 2.1%[27] - Ground lease receivables increased to $1.961 billion as of September 30, 2025, compared to $1.833 billion at the end of 2024, showing a growth of 7.0%[27] - Real estate-related intangible assets, net, decreased slightly to $205.399 million as of September 30, 2025, from $208.731 million at the end of 2024, a decline of 1.1%[27] Debt and Equity - Total debt stood at $4.84 billion, with a total equity of $2.42 billion, resulting in a debt-to-equity ratio of 2.00x[22] - Total liabilities increased to $4.727 billion as of September 30, 2025, from $4.525 billion at the end of 2024, indicating a growth of 4.5%[27] - The total equity of Safehold Inc. shareholders increased to $2.390 billion as of September 30, 2025, from $2.344 billion at the end of 2024, a growth of 2.0%[27] Cash Flow and Funding - Cash and cash equivalents rose to $12.123 million, up from $8.346 million at the end of 2024, representing a significant increase of 45.5%[27] - The company funded four new ground leases totaling $42 million in Q3'25, with $33 million funded and $9 million unfunded[7] - The company has a remaining capital of $400 million for joint ventures with a leading sovereign wealth fund[4] Economic Metrics - Economic yield for Q3'25 was reported at 7.3%, slightly down from 7.4% in Q2'25[3] - Rent coverage ratio improved to 2.4x in Q3'25, compared to 2.5x in Q4'25 year-to-date[3] Strategic Initiatives - Safehold's merger with iStar was completed on March 31, 2023, resulting in the historical financial statements of Old Safehold becoming those of Safehold Inc.[47] - Safehold's GL Plus Fund targets the origination and acquisition of Ground Leases for commercial real estate projects in pre-development phases[44] Valuation and Yield - The portfolio is valued using Aggregate Gross Book Value, which reflects the historical purchase price plus accrued interest on sales-type leases[44] - The Economic Yield is calculated using projected cash flows beginning January 1, 2025, with an initial value equal to the cost of the land, incorporating contractual fixed escalators and an assumed long-term inflation rate of 2.0%[44] - 81% of the portfolio has some form of CPI lookback, while 93% has some form of inflation capture[44] - The Annualized Yield is based on GAAP treatment, assuming a 0% growth/inflation environment for existing legacy ground leases, with 16% of the portfolio earning 3.5% under this metric[44] Financial Metrics - The Debt Effective Interest Rate reflects the all-in stated interest rate over the term of debt from funding through maturity, excluding the effect of discounts and financing costs[44] - The Rent Coverage ratio is based on estimates of stabilized Property NOI, adjusted for material changes, and is used for assessing the ability to meet annualized Cash Rent obligations[44] - The Company tracks Unrealized Capital Appreciation (UCA) as the difference between the Combined Property Value (CPV) and the Aggregate Cost Basis, reflecting the safety of its position in tenant capital structures[44]

Revenue and Billings - Revenue for Q3 2025 was $52.0 million, a decrease of 22% year-over-year from $67.1 million in Q3 2024[5] - Billings for Q3 2025 were $89.2 million, down 20% year-over-year compared to $112.0 million in Q3 2024[5] - Revenue for Q3 2025 was $52,031,000, a decrease of 22.4% compared to $67,057,000 in Q3 2024[22] - Billings for Q3 2025 were $89,193,000, down from $111,958,000 in Q3 2024, a decline of 20.4%[27] - Forecasted revenue for Q4 2025 is projected to be between $51.1 million and $59.1 million[37] - Total billings for Q4 2025 are expected to range from $86.0 million to $96.0 million, including consumer incentives of $26.9 million to $44.9 million[37] Net Loss and Financial Performance - Net Loss for Q3 2025 was $(72.7) million, or $(1.36) per diluted share, compared to a Net Loss of $(145.2) million, or $(2.90) per diluted share in Q3 2024[5] - Net loss for Q3 2025 was $72,673,000, compared to a net loss of $145,182,000 in Q3 2024, indicating an improvement of 50.0%[22] - Net loss for Q3 2025 was $(72.673) million, compared to a net loss of $(145.182) million in Q3 2024, showing an improvement of approximately 50%[30] Adjusted Metrics - Adjusted Contribution for Q3 2025 was $30.0 million, a decrease of 17% year-over-year from $36.4 million in Q3 2024[5] - Adjusted EBITDA for Q3 2025 was $3.2 million, compared to $(1.8) million in Q3 2024[5] - Adjusted EBITDA for Q3 2025 was $3.204 million, a significant recovery from an adjusted EBITDA of $(1.816) million in Q3 2024[30] - Adjusted Contribution for Q4 2025 is expected to be between $29.0 - $35.0 million, a year-over-year decline of 29% to 14%[8] Cash Flow and Expenses - Free Cash Flow for Q3 2025 was $(2.7) million, an improvement from $(3.9) million in Q3 2024[5] - Free cash flow for Q3 2025 was $(2.703) million, an improvement from $(3.869) million in Q3 2024[35] - The company reported stock-based compensation expense of $6,422,000 for Q3 2025, compared to $8,065,000 in Q3 2024, a decrease of 20.4%[24] - Stock-based compensation expense for Q3 2025 was $6.422 million, down from $8.065 million in Q3 2024[33] Assets and Liabilities - Cash and cash equivalents decreased to $43,961,000 as of September 30, 2025, from $65,594,000 at the end of 2024, a decline of 32.9%[25] - Total assets as of September 30, 2025, were $292,807,000, down from $392,711,000 at the end of 2024, a decrease of 25.5%[21] - Total liabilities decreased to $297,511,000 as of September 30, 2025, from $322,718,000 at the end of 2024, a reduction of 7.8%[21] - Stockholders' equity showed a deficit of $4,704,000 as of September 30, 2025, compared to a positive equity of $69,993,000 at the end of 2024[21] User Metrics - Cardlytics monthly qualified users (MQUs) reached 230.3 million, an increase of 21% year-over-year from 190.2 million in Q3 2024[5] Impairment and Costs - The company incurred impairment of goodwill and intangible assets amounting to $58,843,000 in Q3 2025, consistent with the previous year's figure of $131,595,000[22] - Impairment of goodwill and intangible assets for Q3 2025 was $58.843 million, consistent with the impairment recorded in Q3 2024[33] - Total costs and expenses for Q3 2025 were $120,885,000, down from $215,603,000 in Q3 2024, reflecting a reduction of 44.0%[22] Gross Profit - Gross profit for Q3 2025 was $24.300 million, down from $28.552 million in Q3 2024, reflecting a decrease of about 14.5%[28] Share Metrics - The weighted-average number of diluted shares outstanding increased to 53.493 million in Q3 2025 from 50.028 million in Q3 2024[33]

DISCO Announces Third Quarter 2025 Financial Results Total Revenue of $40.9 Million, A Year over Year Increase of 13% AUSTIN, Texas - November 5, 2025 - CS Disco, Inc. ("DISCO") (NYSE: LAW) today announced financial results for its third quarter ended September 30, 2025. "Our strategy to bring large clients and large matters to DISCO continued to gain traction in the third quarter with meaningful acceleration in both software and total revenue," said Eric Friedrichsen, CEO of DISCO. "The growing number of l ...

Revenue and Growth - Consolidated revenue for Q2 FY 2026 was $82.3 million, an increase of $14.4 million or 21.3% compared to Q2 FY 2025, driven by acquisitions and a $5.7 million increase in distribution revenue[100]. - Total revenue for the first six months of FY 2026 was $158.7 million, an increase of $24.2 million or 18.0% compared to the same period in FY 2025[121]. - Service revenue accounted for 64.2% of total revenue in Q2 FY 2026, increasing by $8.8 million or 19.9% year-over-year, despite economic volatility[105]. - Service revenue accounted for 64.3% of total revenue in the first six months of FY 2026, increasing by $14.1 million or 16.1%[122]. - The trailing twelve-month service revenue for Q2 FY 2026 was $195.5 million, reflecting a growth of 11.0% compared to the prior fiscal year[107]. Profitability - Gross profit for Q2 FY 2026 was $26.8 million, up $5.6 million or 26.2% year-over-year, with a consolidated gross margin of 32.5%, an increase of 1.2% from the previous year[101]. - Total gross profit for Q2 FY 2026 was $26.8 million, an increase of $5.6 million or 26.2% compared to Q2 FY 2025, with a gross margin of 32.5%[112]. - Net income for Q2 FY 2026 was $1.3 million, down from $3.3 million in Q2 FY 2025, primarily due to increased administrative costs and interest expenses[103]. - Net income for the first six months of fiscal year 2026 decreased by $3.2 million or 41.1% compared to the same period in fiscal year 2025, with net income as a percentage of revenue dropping from 5.7% to 2.9%[130]. - Adjusted EBITDA for the first six months of fiscal year 2026 was $23.9 million, an increase of $4.8 million or 25.2% from the prior year, with Adjusted EBITDA as a percentage of revenue rising from 14.2% to 15.0%[131]. Operating Expenses - Total operating expenses in Q2 FY 2026 were $23.3 million, an increase of $5.8 million or 33.1% compared to Q2 FY 2025, leading to an operating income of $3.5 million, a decrease of 6.2%[102]. - Total operating expenses for the first six months of FY 2026 were $43.7 million, an increase of $8.7 million or 24.9% compared to the first six months of FY 2025[127]. Margins - Operating margin decreased from 5.5% in Q2 FY 2025 to 4.3% in Q2 FY 2026, indicating increased pressure on profitability[102]. - Service gross profit in Q2 FY 2026 increased by $2.4 million or 16.5%, while service gross margin decreased to 32.2%[113]. - Distribution gross margin in Q2 FY 2026 was 33.2%, an increase of 5.3% from 27.9% in Q2 FY 2025[115]. Cash Flow and Investments - Cash provided by operating activities was $16.5 million in the first six months of fiscal year 2026, up from $15.8 million in the same period of fiscal year 2025, attributed to changes in net working capital[144]. - The company invested $9.0 million in capital expenditures during the first six months of fiscal year 2026, compared to $7.6 million in the same period of fiscal year 2025, focusing on customer-driven expansion[146]. - The company utilized $82.5 million for business acquisitions in the first six months of fiscal year 2026, significantly higher than $15.9 million in the same period of fiscal year 2025[146]. Debt and Financing - As of September 27, 2025, the company had $150.0 million available for borrowing under a new five-year secured revolving credit facility, with $111.9 million outstanding[141]. - The leverage ratio was 2.26 as of September 27, 2025, compared to 0.78 on March 29, 2025, indicating an increase in debt relative to EBITDA[143]. Tax and Interest - The effective tax rate increased to 31.3% in the first six months of fiscal year 2026 from 13.9% in the same period of fiscal year 2025, primarily due to the timing of discrete items[129]. - A 1% change in interest rates would result in a yearly interest expense change of approximately $1.1 million[154]. Other Key Points - Total pending product shipments at the end of Q2 FY 2026 were $7.5 million, an increase of $3.4 million or 82.5% compared to Q2 FY 2025[111]. - Days sales outstanding increased to 62 days as of September 27, 2025, from 59 days as of September 28, 2024, reflecting changes in the timing of collections[144]. - Adjusted diluted earnings per share for the first six months of fiscal year 2026 was $1.03, compared to $1.20 in the same period of fiscal year 2025[137]. - Approximately 90% of total revenues for the first six months of fiscal year 2026 were denominated in U.S. dollars[156]. - The acquisition of Essco Calibration is the largest deal in the company's history, enhancing its calibration service portfolio and market presence[150]. - The company expects a return to single-digit service organic revenue growth in the second half of fiscal 2026[151]. - The estimated income tax rate for the full fiscal year 2026 is projected to be between 30% and 32%[152].

SAN FRANCISCO, CA, November 5, 2025 — Nextdoor Holdings, Inc. (NYSE: NXDR), the essential neighborhood network, today reported financial results for the third quarter ended September 30, 2025. Nextdoor's highlighted metrics for the quarter ended September 30, 2025 include: "We saw steady execution and progress in Q3, delivering our highest-ever quarterly revenue," said Nextdoor CEO Nirav Tolia. "Our financial and operational discipline continue to drive growth and expand non-GAAP profitability, and we remai ...